Submissions from 2021
Dr. Mease et al reply., Philip Mease, Robert R McLean, Blessing Dube, Mei Liu, Sabrina Rebello, Meghan Glynn, Esther Yi, Yujin Park, and Alexis Ogdie
Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry., Philip Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, and David H Collier
IL-23 and axial disease: do they come together?, Philip Mease and Filip van den Bosch
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study., Peter Nash, Philip Mease, Bruce Kirkham, Atul Singhal, Erhard Quebe-Fehling, Luminita Pricop, and Corine Gaillez
The ASAS-OMERACT core domain set for axial spondyloarthritis., V Navarro-Compán, A Boel, A Boonen, Philip Mease, R Landewé, U Kiltz, M Dougados, X Baraliakos, W Bautista-Molano, H Carlier, P Chiowchanwisawakit, H Dagfinrud, N de Peyrecave, B El-Zorkany, L Fallon, K Gaffney, M Garrido-Cumbrera, L S Gensler, N Haroon, Y H Kwan, P M Machado, W P Maksymowych, D Poddubnyy, M Protopopov, S Ramiro, B Shea, I H Song, S van Weely, and D van der Heijde
Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry., Alexis Ogdie, Taylor Blachley, Paul R Lakin, Blessing Dube, Robert R McLean, Peter Hur, and Philip Mease
Establishing core domain sets for Chronic Nonbacterial Osteomyelitis (CNO) and Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): A report from the OMERACT 2020 special interest group., Melissa Oliver, Aruni Jayatilleke, Eveline Wu, Farzana Nuruzzaman, Cassyanne Aguiar, Aleksander Lenert, Micol Romano, Gabriele Simonini, Samir Shah, Matthew Hollander, Alhanouf Alsaleem, Emily Fox, Alexander Theos, Athimalaipet V Ramanan, Anja Schnabel, Sivia Lapidus, Lori Tucker, Karen Onel, Seza Ozen, Fatma Dedeoglu, Polly J Ferguson, Beverley Shea, Jonathan Akikusa, Christian Hedrich, Philip Mease, and Yongdong Zhao
Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies., Ana-Maria Orbai, M Elaine Husni, Dafna D Gladman, Ying Ying Leung, Stefan Siebert, William Tillett, Marijn Vis, Olivier Chambenoit, Xiangyi Meng, and Philip J Mease
Biopsychosocial rehabilitation for inflammatory arthritis and osteoarthritis: A systematic review and meta-analysis of randomized trials., Morten B Pedersen, Peter Thinggaard, Rinie Geenen, Marianne U Rasmussen, Maarten De Wit, Lyn March, Philip Mease, Ernest Choy, Philip G Conaghan, Lee Simon, Anne Faber Hansen, Simon Tarp, Berit Schiøttz-Christensen, Carsten B Juhl, Sabrina M Nielsen, Kirstine Amris, and Robin Christensen
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study., Lourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, Cheryl F Rosen, Christopher Ritchlin, Lihi Eder, Philip Mease, Soumya Reddy, Alexis Ogdie, Joseph F Merola, and Jose U Scher
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting., Lourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Philip J Mease, Alexis Ogdie, Vibeke Strand, and Joseph F Merola
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting., Lourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, April W Armstrong, Lihi Eder, Philip J Mease, Alexis Ogdie, Vibeke Strand, and Joseph F Merola
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)., Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, Jürgen Braun, Laura C Coates, Vinod Chandran, Torsten Diekhoff, Floris A van Gaalen, Lianne S Gensler, Niti Goel, Alice B Gottlieb, Désirée van der Heijde, Philip S Helliwell, Kay Geert A Hermann, Deepak Jadon, Robert G Lambert, Walter P Maksymowych, Philip Mease, Peter Nash, Fabian Proft, Mikhail Protopopov, Joachim Sieper, Murat Torgutalp, and Dafna D Gladman
Axial involvement in psoriatic arthritis: An update for rheumatologists., Denis Poddubnyy, Deepak R Jadon, Filip Van den Bosch, Philip J Mease, and Dafna D Gladman
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis., Proton Rahman, Philip J Mease, Philip S Helliwell, Atul Deodhar, Laure Gossec, Arthur Kavanaugh, Alexa P Kollmeier, Elizabeth C Hsia, Bei Zhou, Xiwu Lin, May Shawi, Chetan S Karyekar, and Chenglong Han
Pooled Safety Results Through One Year of Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis., Proton Rahman, Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Philip J Mease, Alice B Gottlieb, Shelly Kafka, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang, and Iain B McInnes
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study., Marie Skougaard, Tanja S Jørgensen, Mia J Jensen, Christine Ballegaard, Jørgen Guldberg-Møller, Alexander Egeberg, Robin Christensen, Peter Benzin, Zara R Stisen, Joseph F Merola, Laura C Coates, Vibeke Strand, Philip Mease, and Lars Erik Kristensen
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting., Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Philip J Mease, Alexis Ogdie, Denis O'Sullivan, Stephen R Pennington, Thorvardur Löve, Alberto Cauli, Leonieke van Mens, Robin Waxman, Jose U Scher, Anne Barton, Christopher T Ritchlin, and Oliver FitzGerald
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting., Carmel Stober, Deepak R Jadon, April W Armstrong, Vinod Chandran, Maarten de Wit, Philip S Helliwell, Philip Mease, Alexis Ogdie, Denis O'Sullivan, Stephen R Pennington, Thorvardur Löve, Alberto Cauli, Leonieke van Mens, Robin Waxman, Jose U Scher, Anne Barton, Christopher T Ritchlin, and Oliver FitzGerald
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination., Vibeke Strand, Philip Mease, Ervant J Maksabedian Hernandez, Bradley S Stolshek, Lyrica X H Liu, David H Collier, Gregory Kricorian, and Joseph F Merola
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1., Vibeke Strand, Philip Mease, Enrique R Soriano, Mitsumasa Kishimoto, Carlo Salvarani, Christopher D Saffore, Patrick Zueger, Erin McDearmon-Blondell, Koji Kato, and Dafna D Gladman
Familial cold autoinflammatory syndrome with rheumatoid arthritis., Brooke Walterscheid, Jeannie Nguyen, Swetha Gadwala, Goutam Shome, Michelle Tarbox, and James A Tarbox
Submissions from 2020
Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews., Rikke A Andreasen, Lars E Kristensen, Xenofon Baraliakos, Vibeke Strand, Philip Mease, Maarten de Wit, Torkell Ellingsen, Inger Marie J Hansen, Jamie Kirkham, George A Wells, Peter Tugwell, Lara Maxwell, Maarten Boers, Kenneth Egstrup, and Robin Christensen
Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab., Laura C Coates, Sonya Abraham, William Tillett, Philip Mease, Sofia Ramiro, Tianshuang Wu, Xin Wang, Aileen L Pangan, and In-Ho Song
Methotrexate in Psoriasis and Psoriatic Arthritis., Laura C Coates, Joseph F Merola, Suzanne M Grieb, Philip Mease, and Kristina Callis Duffin
Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis., Laura C Coates, Joseph F Merola, Philip Mease, Alexis Ogdie, Dafna D Gladman, Vibeke Strand, Leonieke J J van Mens, Lyrica Liu, Priscilla K Yen, David H Collier, Gregory Kricorian, James B Chung, and Philip S Helliwell
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study., Laura C Coates, Peter Nash, Tore K Kvien, Laure Gossec, Philip Mease, Lawrence Rasouliyan, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi, Corine Gaillez, and Josef S Smolen
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial., Atul Deodhar, Philip Mease, Proton Rahman, Victoria Navarro-Compán, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Luis Leon, Mingyang Shan, Ann Leung, Kurt De Vlam, and Vibeke Strand
GRAPPA 2019 Project Report., Niti Goel, Laura C Coates, Gabriele De Marco, Lihi Eder, Oliver FitzGerald, Philip S Helliwell, Ying Ying Leung, Walter P Maksymowych, Philip Mease, Mikkel Østergaard, Denis O'Sullivan, Denis Poddubnyy, Christopher T Ritchlin, and Dafna D Gladman
Secukinumab Efficacy in Psoriatic Arthritis: Machine Learning and Meta-analysis of Four Phase 3 Trials., Alice B Gottlieb, Philip Mease, Bruce Kirkham, Peter Nash, Alejandro C Balsa, Bernard Combe, Jürgen Rech, Xuan Zhu, David James, Ruvie Martin, Gregory Ligozio, Ken Abrams, and Luminita Pricop
Relation between fatigue and ACR response in patients with psoriatic arthritis treated with TNFi therapy: a population-based cohort study., Tanja Schjødt Jørgensen, Marie Skougaard, Rebekka Lund Hansen, Christine Ballegaard, Philip Mease, Vibeke Strand, Lene Dreyer, and Lars Erik Kristensen
Clinical trial discrimination of physical function instruments for psoriatic arthritis: A systematic review., Ying-Ying Leung, Richard Holland, Ashish J Mathew, Christine Lindsay, Niti Goel, Alexis Ogdie, Ana-Maria Orbai, Pil Hojgaard, Jeffrey Chau, Laura C Coates, Vibeke Strand, Dafna D Gladman, Robin Christensen, William Tillett, and Philip Mease
Appraisal of candidate instruments for assessment of the physical function domain in patients with psoriatic arthritis., Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Pil Hojgaard, Richard Holland, Niti Goel, Jeffrey Chau, Laura C Coates, Vibeke Strand, Dafna D Gladman, Philip Mease, Robin Christensen, and William Tillett
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates., Ying Ying Leung, William Tillett, Ana-Maria Orbai, Alexis Ogdie, Lihi Eder, Laura C Coates, Richard Holland, Anna Antony, Niti Goel, Philip Mease, Vibeke Strand, Oliver FitzGerald, Maarten de Wit, Christine A Lindsay, Kristina Callis Duffin, and Dafna D Gladman
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis., Sara C Martinez, Mohamed Mohamed, Jessica Potts, Abhishek Abhishek, Edward Roddy, Michael Savage, Aditya Bharadwaj, Chun Shing Kwok, Rodrigo Bagur, and Mamas A Mamas
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis., Sara C Martinez, Mohamed Mohamed, Jessica Potts, Abhishek Abhishek, Edward Roddy, Michael Savage, Aditya Bharadwaj, Chun Shing Kwok, Rodrigo Bagur, and Mamas A Mamas
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks., Helena Marzo-Ortega, Philip Mease, Proton Rahman, Victoria Navarro-Compán, Vibeke Strand, Maxime Dougados, Bernard Combe, James Cheng-Chung Wei, Xenofon Baraliakos, Theresa Hunter, David Sandoval, Xiaoqi Li, Baojin Zhu, Louis Bessette, and Atul Deodhar
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial., Iain B McInnes, Frank Behrens, Philip Mease, Arthur Kavanaugh, Christopher Ritchlin, Peter Nash, Jordi Gratacós Masmitja, Philippe Goupille, Tatiana Korotaeva, Alice B Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, and Luminita Pricop
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through 1 Year in Biologic-naïve Psoriatic Arthritis Patients., Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng, Yusang Jiang, Bei Zhou, Yanli Zhuang, Désirée van, der Heijde, and Philip Mease
Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management., Philip Mease
New treatments for PsA meet targeted therapy goals., Philip Mease
Preface to the psoriatic arthritis supplement., Philip Mease
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data., Philip Mease, Christina Charles-Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel Kremer, Jeffrey Greenberg, Wendi Malley, Alina Onofrei, Keith S Kanik, Daniela Graham, Cunshan Wang, Carol Connell, Hernan Valdez, Manfred Hauben, Eric Hung, Ann Madsen, Thomas V Jones, and Jeffrey R Curtis
Reply to Letter to the Editor on Mease et al., Philip Mease, David H Collier, Gregory Kricorian, and James B Chung
Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study., Philip Mease, M Elaine Husni, Soumya D Chakravarty, Shelly Kafka, Dennis Parenti, Lilianne Kim, Kim Hung Lo, Elizabeth C Hsia, and Arthur Kavanaugh
Evaluation of changes in skin and joint outcomes and associated treatment changes in PsA: Experience from the Corrona PsA/SpA Registry., Philip Mease, Carol J Etzel, William Huster, April Armstrong, Talia Muram, Jeffrey Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi J Murage, Jeffrey D Greenberg, and William Malatestinic
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study., Philip Mease, Dafna D Gladman, Atul Deodhar, Dennis G McGonagle, Peter Nash, Wolf-Henning Boehncke, Alice Gottlieb, Xie L Xu, Stephen Xu, Elizabeth C Hsia, Chetan S Karyekar, and Philip S Helliwell
Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials., Philip Mease, Dafna D Gladman, Juan J Gomez-Reino, Stephen Hall, Arthur Kavanaugh, Eric Lespessailles, Georg Schett, Maria Paris, Nikolay Delev, Lichen Teng, and Jürgen Wollenhaupt
Treatment to Target in Psoriatic Arthritis with Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations., Philip Mease, Dafna D Gladman, Alexis Ogdie, Laura C Coates, Frank Behrens, Arthur Kavanaugh, Iain Mcinnes, Rubén Queiro, Benoit Guerette, Michele Brunori, Lichen Teng, and Josef S Smolen
Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials., Philip Mease, Philip S Helliwell, Kasper Fjellhaugen Hjuler, Kyle Raymond, and Iain McInnes
Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial., Philip Mease, M Elaine Husni, Shelly Kafka, Soumya D Chakravarty, Diane D Harrison, Kim Hung Lo, Stephen Xu, Elizabeth C Hsia, and Arthur Kavanaugh
Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis., Philip J Mease, Iain B McInnes, Vibeke Strand, Oliver FitzGerald, Harris A Ahmad, Yedid Elbez, and Subhashis Banerjee
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study., Philip Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Juergen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Eumorphia Maria Delicha, Luminita Pricop, and Shephard Mpofu
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2., Philip Mease, Apinya Lertratanakul, Jaclyn K Anderson, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Eva Dokoupilova, Mauro Keiserman, Xin Wang, Sheng Zhong, Reva M McCaskill, Patrick Zueger, Aileen L Pangan, and William Tillett
Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real- World Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Mei Liu, Sabrina Rebello, Winnie Hua, Robert R McLean, Peter Hur, and Alexis Ogdie
Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Mei Liu, Sabrina Rebello, Winnie Hua, Robert R McLean, Esther Yi, Yujin Park, and Alexis Ogdie
Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Mei Liu, Sabrina Rebello, Robert R McLean, Blessing Dube, Meghan Glynn, Peter Hur, and Alexis Ogdie
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial., Philip Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Désirée van der Heijde, and Iain B McInnes
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial., Philip Mease, Josef S Smolen, Frank Behrens, Peter Nash, Soyi Liu Leage, Lingnan Li, Hasan Tahir, Melinda Gooderham, Eswar Krishnan, Hong Liu-Seifert, Paul Emery, Sreekumar G Pillai, and Philip S Helliwell
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study., Peter Nash, Laura C Coates, Alan J Kivitz, Philip Mease, Dafna D Gladman, José A Covarrubias-Cobos, Oliver FitzGerald, Dona Fleishaker, Cunshan Wang, Joseph Wu, Ming-Ann Hsu, Sujatha Menon, Lara Fallon, Ana Belén Romero, and Keith S Kanik
Measuring Outcomes in Psoriatic Arthritis., Alexis Ogdie, Laura C Coates, and Philip Mease
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis., Alexis Ogdie, Kurt de Vlam, Iain B McInnes, Philip J Mease, Philip Baer, Tatjana Lukic, David Gruben, Kenneth Kwok, Cunshan Wang, Ming-Ann Hsu, and Anna Maniccia
Measuring Outcomes in Axial Spondyloarthritis., Alexis Ogdie, Alí Duarte-García, Mark Hwang, Victoria Navarro-Compán, Désirée van der Heijde, and Philip Mease
Descriptive Comparisons of the Impact of Apremilast and Methotrexate Monotherapy in Oligoarticular Psoriatic Arthritis: the Corrona Psoriatic Arthritis/Spondyloarthritis Registry Results., Alexis Ogdie, Mei Liu, Meghan Glynn, Kelechi Emeanuru, Leslie Harrold, Sven Richter, Benoit Guerette, and Philip Mease
Patient's experience of psoriatic arthritis: a conceptual model based on qualitative interviews., Alexis Ogdie, Kaleb Michaud, Miroslawa Nowak, Rachel Bruce, Sarah Cantor, Carlijn Hintzen, and Philip Mease
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients., Ana-Maria Orbai, Iain B McInnes, Laura C Coates, M Elaine Husni, Dafna D Gladman, Laure Gossec, Luminita Pricop, Olivier Chambenoit, Xiangyi Meng, and Philip Mease
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations., Shannon M Smith, Robert H Dworkin, Dennis C Turk, Michael McDermott, Christopher Eccleston, John T Farrar, Michael C Rowbotham, Zubin Bhangwagar, Laurie B Burke, Penney Cowan, Susan S Ellenberg, Scott R Evans, Roy L Freeman, Louis P Garrison, Smriti Iyengar, Alejandro Jadad, Mark P Jensen, Roderick Junor, Cornelia Kamp, Nathaniel P Katz, J Patrick Kesslak, Ernest A Kopecky, Dmitri Lissin, John D Markman, Philip Mease, Alec B O'Connor, Kushang V Patel, Srinivasa N Raja, Cristina Sampaio, David Schoenfeld, Jasvinder Singh, Ilona Steigerwald, Vibeke Strand, Leslie A Tive, Jeffrey Tobias, Ajay D Wasan, and Hilary D Wilson
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52., Josef S Smolen, Philip Mease, Hasan Tahir, Hendrik Schulze-Koops, Inmaculada de la Torre, Lingnan Li, Maja Hojnik, Christophe Sapin, Masato Okada, Roberto Caporali, Jordi Gratacós, Philippe Goupille, Soyi Liu Leage, Sreekumar Pillai, and Peter Nash
An interferon-gamma release assay as a novel biomarker in systemic lupus erythematosus., Jenna L Thomason, Uchechukwu M Obih, David M Koelle, Christian Lood, and And Grant Hughes
Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps., William Tillett, Neil McHugh, Ana-Maria Orbai, Alexis Ogdie, Ying Ying Leung, Laura C Coates, Philip Mease, Dafna D Gladman, Mel Brooke, Jon Packham, Denis O'Sullivan, Oliver FitzGerald, and Philip S Helliwell
Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research., Désirée van der Heijde, Dafna D Gladman, Arthur Kavanaugh, and Philip Mease
Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5., Désirée van der Heijde, Philip Mease, Robert B M Landewé, Proton Rahman, Hasan Tahir, Atul Singhal, Elke Boettcher, Sandra Navarra, Xuan Zhu, Gregory Ligozio, Aimee Readie, Shephard Mpofu, and Luminita Pricop
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting., Robin Waxman, Carmel Stober, Deepak R Jadon, Ana-Maria Orbai, Vinod Chandran, Alexis Ogdie, Stephen R Pennington, Maarten de Wit, Denis O'Sullivan, Philip Mease, April W Armstrong, Kristina Callis Duffin, Philip S Helliwell, Leonieke J J van Mens, Christopher T Ritchlin, and Oliver FitzGerald
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019., Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ferry C Breedveld, Joachim Kalden, Josef S Smolen, and Daniel Furst
Submissions from 2019
Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population., Diana Brixner, Manish Mittal, David T Rubin, Philip Mease, Harry H Liu, Matthew Davis, Arijit Ganguli, and A Mark Fendrick
Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018., Alessandro Chiarotto, Ulrike Kaiser, Ernest Choy, Robin Christensen, Philip G Conaghan, Mary Cowern, Michael Gill, Maarten de Wit, Elizabeth Gargon, Ben Horgan, Jamie J Kirkham, Lee S Simon, Jasvinder A Singh, Peter Tugwell, Dennis C Turk, and Philip Mease
Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018., Alessandro Chiarotto, Ulrike Kaiser, Ernest Choy, Robin Christensen, Philip G Conaghan, Mary Cowern, Michael Gill, Maarten de Wit, Elizabeth Gargon, Ben Horgan, Jamie J Kirkham, Lee S Simon, Jasvinder A Singh, Peter Tugwell, Dennis C Turk, and Philip Mease
Measurement properties of the minimal disease activity criteria for psoriatic arthritis., Laura C Coates, Vibeke Strand, Hilary Wilson, Dennis Revicki, Brad Stolshek, Ahmed Samad, James B Chung, Dafna Gladman, and Philip Mease
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies., Laura C Coates, Johan K Wallman, Dennis McGonagle, Georg A Schett, Iain B McInnes, Philip Mease, Lawrence Rasouliyan, Erhard Quebe-Fehling, Darren L Asquith, Andreas E R Fasth, Luminita Pricop, and Corine Gaillez
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies., Laura C Coates, Johan K Wallman, Dennis McGonagle, Georg A Schett, Iain B McInnes, Philip Mease, Lawrence Rasouliyan, Erhard Quebe-Fehling, Darren L Asquith, Andreas E R Fasth, Luminita Pricop, and Corine Gaillez
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data., A Deodhar, Philip Mease, I B McInnes, X Baraliakos, K Reich, A Blauvelt, C Leonardi, B Porter, A Das Gupta, A Widmer, L Pricop, and T Fox
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap., Atul Deodhar, Lianne S Gensler, Marina Magrey, Jessica A Walsh, Adam Winseck, Daniel Grant, and Philip Mease
Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report., Alí Duarte-García, Ying Ying Leung, Laura C Coates, Dorcas Beaton, Robin Christensen, Ethan T Craig, Maarten de Wit, Lihi Eder, Lara Fallon, Oliver FitzGerald, Dafna D Gladman, Niti Goel, Richard Holland, Chris Lindsay, Lara Maxwell, Philip Mease, Ana Maria Orbai, Bev Shea, Vibeke Strand, Douglas J Veale, William Tillett, and Alexis Ogdie
GRAPPA 2018 Project Report., Niti Goel, Oliver FitzGerald, Dafna D Gladman, Philip S Helliwell, Arthur Kavanaugh, Walter P Maksymowych, Philip Mease, Christopher T Ritchlin, and Laura C Coates
Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study., Pil Højgaard, Karen Ellegaard, Sabrina Mai Nielsen, Robin Christensen, Jørgen Guldberg-Møller, Christine Ballegaard, Lene Dreyer, Philip Mease, Maarten de Wit, Lone Skov, Bente Glintborg, Henning Bliddal, Else Marie Bartels, Kirstine Amris, and Lars Erik Kristensen
Prevalence of Crystals in Knee Osteoarthritis: Experience From Patients Undergoing Arthroscopic Procedures., Robert Ike, Amrutha Baskaran, Jeannie Chao, Andrew L Concoff, Christopher W Wu, Bob Sun, Paul H Brion, Erin L Arnold, David J Klashman, John FitzGerald, and Kenneth C Kalunian
Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting., Deepak R Jadon, Vinod Chandran, Alexis Ogdie, Stephen R Pennington, Carmel Stober, Dafna D Gladman, Maarten de Wit, Denis O'Sullivan, Philip Mease, April W Armstrong, Kristina Callis Duffin, Conor Magee, Philip Helliwell, Christopher T Ritchlin, and Oliver FitzGerald
Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis., Arthur Kavanaugh, Dafna D Gladman, Christopher J Edwards, Georg Schett, Benoit Guerette, Nikolay Delev, Lichen Teng, Maria Paris, and Philip Mease
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set., Ying Ying Leung, Ana-Maria Orbai, Alexis Ogdie, Laura C Coates, Maarten de Wit, Kristina Callis Duffin, Lihi Eder, Dafna D Gladman, Niti Goel, Philip Mease, Vibeke Strand, Oliver FitzGerald, and William Tillett
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a, Iain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, Manuela Le Bars, Subhashis Banerjee, Harris A Ahmad, Yedid Elbez, and Philip Mease
Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis., Philip Mease
Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results., Philip Mease
Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting., Philip Mease, Neil A Accortt, Sabrina Rebello, Carol J Etzel, Ryan W Harrison, Girish A Aras, Mahdi M F Gharaibeh, Jeffrey D Greenberg, and David H Collier
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry., Philip Mease, Carol J Etzel, William J Huster, Talia M Muram, April W Armstrong, Jeffrey R Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi James Murage, Jeffrey D Greenberg, and William N Malatestinic
Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase 3 Trial., Philip Mease, Dafna D Gladman, David H Collier, Christopher T Ritchlin, Philip S Helliwell, Lyrica Liu, Gregory Kricorian, and James B Chung
Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry., Philip Mease, Chitra Karki, Mei Liu, YouFu Li, Bernice Gershenson, Hua Feng, Peter Hur, and Jeffrey D Greenberg
Axial Spondyloarthritis, Philip Mease and Muhammad Asim Khan
Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study., Philip Mease, Clive Liu, Evan Siegel, Heather Richmond, Meijing Wu, Liang Chen, Kevin Douglas, and Benjamin Lockshin
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries., Philip Mease, Mei Liu, Sabrina Rebello, Hyungjoo Kang, Esther Yi, Yujin Park, and Jeffrey D Greenberg
Utilization of the validated Psoriasis Epidemiology Screening Tool (PEST) to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry., Philip Mease, J B Palmer, P Hur, B E Strober, M Lebwohl, C Karki, G W Reed, C J Etzel, J D Greenberg, and P S Helliwell
